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Protein immobilization techniques play an important role in the development of assays for disease diagnosis
and drug discovery. However, many of these approaches are not applicable to transmembrane proteins. G
protein-coupled receptors (GPCRs) are the largest protein superfamily encoded by the human genome and
are targeted by a quarter of all prescription drugs. GPCRs are highly dynamic and sensitive to changes in the
ambient environment, and current immobilization methodologies are not suitable for GPCRs. We used
haloalkane dehalogenase (Halo) as an immobilization tag fused to the b2-adrenoceptor (b2-AR),
angiotensin II type 1 (AT1) and angiotensin II type 2 (AT2) receptors. The engineered Halo-tag covalently
binds to a specific substrate chloroalkane through Asp 106 in the catalytic pocket. The Halo-tagged
GPCRs were expressed in Escherichia coli at a suitable yield. Accordingly, we loaded cell lysate
containing Halo-tagged GPCRs onto a macroporous silica gel coated with chloroalkane. Morphological
characterization indicated a homogeneous monolayer of immobilized Halo-tagged GPCRs on the silica
gel surface. The immobilized receptors proved to be surrounded by specific bound phospholipids
including PG C18:1/C18:1. We observed a radio-ligand binding ability and ligand-induced conformational
changes in the immobilized GPCRs, suggesting the preservation of bioactivity. This method is a one-step
approach for the specific immobilization of GPCRs from cell lysates and validates that immobilized
receptors retain canonical ligand binding capacity. Our immobilization strategy circumvents labor-
intensive purification procedures and minimizes loss of activity. The immobilized receptors can be
applied to high-throughput drug and interaction partner screening for GPCRs.Introduction
Anchoring protein-based techniques1–5 are central to biomarker
detection, proteomic screens, drug discovery and the systemic
study of biological mechanisms at the molecular level.6 These
methods require the immobilization of target proteins onto
solid scaffolds. As such, one challenge for these techniques is
the conservation of target protein bioactivity duringtechnology in Western China, Ministry of
west University, Xi’an 710069, China.
8302686; Tel: +86 029 88302686
, University of North Carolina at Chapel
Cambridge, Cambridge CB2 1PD, UK
tion (ESI) available. See DOI:
k.immobilization, and this obstacle is of particular concern with
regard to transmembrane proteins.7,8
Nonspecic methodologies, including physical adsorption
and covalent methods, are commonly utilized for protein
immobilization. These methods can lead to protein denatur-
ation and heterogeneous orientations of immobilized proteins.
As an alternative, site-specic immobilization is an optimal
approach used to fabricate homogeneous, reproducible and
controllable substrate-protein surfaces.9 Site specicity can be
achieved with the noncovalent recognition of biomolecules.10–13
This method is challenged by linkage stability and the stability
of immobilized protein. Furthermore, covalent site-specic
immobilization is superior for minimizing protein dissocia-
tion. Based on ongoing developments in click chemistry,
a number of protein immobilization methods have been
developed.14–17 These methodologies rely on endogenous amino
acids that might lead to undesired proteins bound to the
surface. Impressive achievements in protein engineering have
led to the use of O6-alkylguanine-DNA alkyltransferase andThis journal is © The Royal Society of Chemistry 2018
























































































View Article Onlinefarnesyltransferase as tags to immobilize target proteins on
surfaces.18,19 This strategy has mainly been applied to cytosolic
proteins with good solubility in the aqueous phase but rarely to
transmembrane proteins with important biological functions
such as G protein-coupled receptors (GPCRs).
GPCRs are associated with almost every major therapeutic
category, including pain, asthma, inammation, obesity, and
cancer as well as cardiovascular, metabolic, gastrointestinal and
central nervous system diseases. They represent the single most
important class of drug targets – 50% of current drugs target
GPCRs, and 20% of the top 50 best-selling drugs target
GPCRs.20 The dominance of GPCRs as a drug target class
highlights the need for functional molecular assays to assess
activation and screening for specic ligands,21 which can be
addressed with a strategy based on GPCR immobilization.
However, GPCR immobilization is challenging, as the receptors
are sensitive to changes in the chemical environment. Thus,
improved covalent, site-specic immobilization techniques are
urgently needed.
In this paper, we engineered haloalkane dehalogenase
(Halo) as a tag on the C-terminus of three GPCRs: b2-adreno-
ceptor (b2-AR), angiotensin II type 1 (AT1) and angiotensin II
type 2 (AT2). We modied a macroporous silica gel with 6-
chlorohexanoic acid derivatives that are Halo-tag substrates. We
captured the three Halo-tagged receptors from an Escherichia
coli lysate onto the gel surface. The immobilized receptors
exhibited ligand-binding activities and ligand-induced confor-
mational changes. This study reports for the rst time that
bioorthogonal chemical reactions between enzymes and
substrates have been applied to immobilized b2-AR, AT1 and
AT2 receptors. Our approach is fast, robust, high-yielding, che-
moselective and minimizes GPCR activity loss.Results and discussion
E. coli expression of Halo-tagged receptors
As Halo-tags form covalent intermediates by removing halides
from aliphatic hydrocarbons,22,23 they have been successfully
applied in the expression and purication of soluble proteins
and cell surface labelling.24–27 In E. coli, we expressed b2-AR, AT1
and AT2 receptors fused with a Halo-tag at their C-terminusFig. 1 SDS-PAGE analysis of cell lysates from E. coli expressing Halo-
tagged b2-AR, AT1 or AT2. Lane M: protein marker; Lane A: auto-
induction growth medium; Lane L: LB medium; Lane S: supernatant;
Lane P: precipitation.
This journal is © The Royal Society of Chemistry 2018aer auto-induction. The cell lysates were directly analysed by
SDS-PAGE (Fig. 1). In the marker lane, a linear relationship was
established between mobility and the logarithm of the molec-
ular weight, which was used to calculate themolecular weight of
the experimental bands. Compared with the LB media lanes,
a sharp new band was visible in the auto-induction media.
Further analysis of cells incubated in these media showed that
a dominant band exhibiting mobility consistent with the ex-
pected protein appeared in the supernatant of the cell lysates.
The molecular weights of the three Halo-tagged receptors were
determined to be 80.0, 74.5 and 74.8 kDa. Importantly, it
demonstrates that milligram quantities of functional, stable
GPCRs can be expressed, a challenging task for high-resolution
structural studies and other research.Selection of a halide linker for halo-receptor immobilization
As a powerful anchor, the Halo-tag has been successfully
applied in the development of diverse assays, revealing
a complexity inherent to cellular processes.28–32 The length and
structure of the linker are critical for assay stability.33 We
designed ve linkers ending with chlorine groups (ESI Table 1†)
and tested their reactivity with Halo-tagged receptors. Using the
Halo-tag® TMR ligand as a marker ligand, the reactivity was
determined from the uorescence signal of residual receptors
that were not immediately immobilized aer the reaction. Our
results indicated that the Halo-tagged receptors covalently bind
to all ve linkers to release the halide, but linker 3 exhibited the
best reactivity. To evaluate the chemical properties responsible
for the reactivity difference, we calculated the partition coeffi-
cient (X log P) values, an index of hydrophobicity. Linker reac-
tivity was correlated to the X log P value when the total atom
number of the spacer arm was less than 13. Linker 3 demon-
strated much higher reactivity than linker 2 although their
spacer arms contained the same number of carbons. This might
ascribe the presence of a large benzene ring in linker 2 that
prevents the chloroalkane from reaching the Halo-tag catalytic
site. Linker 4 contains one more carbon atom than linker 3
before the chloride, resulting in a higher X log P value of 1.2. It
demonstrated lower reactivity partly because the total atom
number of the spacer between the enzyme and the silica gel
surface was too long. These results indicate that bulky
substrates with higher hydrophobicity are less likely to form an
ester bond with the fused Halo-tag and provide a strategy to
design new linkers to ensure the efficient immobilization of
Halo-tagged proteins. In summary, we expressed Halo-tagged
GPCRs and demonstrated that our approach can be used to
covalently capture transmembrane receptors from the cell lysate
mixture efficiently in one step.
Because the receptors in the E. coli lysates utilize the Halo-
tag to react specically with a linker-derivatized silica gel, this
methodology can minimize the nonspecic attachment of
proteins. The nonspecic immobilization of proteins by tradi-
tional chemical means results in signicant activity loss,
making the method described herein particularly suitable for
quantitative GPCR immobilization with negligible activity loss.
Using previous techniques, ionic detergent micelles and lipid-Chem. Sci., 2018, 9, 446–456 | 447
























































































View Article Onlinedetergent micelles were used to dissociate receptors from their
natural environment.34 However, detergents oen cause
receptor misfolding and degradation. In contrast, this meth-
odology combines the use of lysozymes and low-frequency
sonication for optimal receptor extraction.
Surface characterization
The search for a universally applicable protocol to characterize
protein-coated supports continues due to the diversity of
materials used to immobilize proteins. A wide range of analyt-
ical methods has been employed to solve this problem,
including elemental analysis, thermal analysis and electron
microscopy. Although such analyses can provide physical and
chemical information, the functionality of the immobilized
proteins remains unknown. We used laser scanning confocal
microscopy (LSM) to conrm normal receptor function in
receptor-conjugated silica gel microspheres in addition to
physical characterization via X-ray photoelectron spectroscopy
(XPS), cryo-eld emission scanning electron microscopy (SEM)
and high-resolution transmission electron microscopy (TEM).
Composite characterization
The surface features of the linker- and receptor-conjugated
microspheres were rst characterized by XPS. A survey scan of
the bare silica gel provided specic signals for O 1s, Si 2s and Si
2p with a molar ratio of 1 : 2 (O : Si), indicating satisfactory gel
purity, as the surface of the silica microspheres is reported to be
either siloxane (Si–O–Si) or silanol (Si–OH).33 Thus, it was
reasonable to assume that the C 1s peak from the immobilized
receptors comes from the linker and protein layer. To verify this
assumption, we assessed the XPS character of the control
supports (aminopropyl gel and 6-chlorohexanoic acid coated
gel) and the three immobilized receptors. Compared with the
bare silica gel, the aminopropyl gel and 6-chlorohexanoic acid-
coated gel exhibited appreciable C 1s signals with a carbon
content of 0.97 and 1.06 atom%, respectively, indicating
successful modication of the silica by the linkers.
The O 1s spectra for the receptor-conjugated microspheres
showed a broad featureless peak of 1.4 eV full width at half-
maximum (FWHM) at 532.1 eV with a high BE shoulder. N 1s
was also featureless, with peaks at 403 eV. These results are
similar to the characteristics of free peptides.35 Thus, the C 1s
peak was the most promising signal for XPS characterization of
the three receptors. The C 1s signal from the silica-linker-
modied receptors exhibited six different signals at 284.92,
286.14, 286.93, 288.30, 288.94 and 289.23 eV (ESI Table 2†),
which were tted by Gaussian–Lorentzian functions using
a Shirley-type background. The peaks were attributed to carbon
atoms with C–C (284.92 eV), C–N (286.14 eV), C–O (286.93 eV),
O]C–N (288.30 eV), O]C–OH (288.94 eV) and C–N3 (289.23 eV)
congurations. The peak positions agree with previously re-
ported binding energies for low molecular weight organic
compounds.36,37 The chemical shi intensities at these six
positions were proportional to the population of the particular
carbon type, and these chemical shis were consistent with the
six potential chemical environments of the carbon atoms in the448 | Chem. Sci., 2018, 9, 446–456proteins. There was little difference between the C 1s shape for
free or immobilized receptors because the number of carbon
atoms in the linker was at least 1000 times less than that in the
free receptors. All of the three immobilized receptors exhibited
much higher carbon content (59.6 atom%) than the control
supports, indicating that these receptors were successfully
conjugated onto the silica gel microspheres.Morphological analysis
SEM images of the bare silica gel exhibited a spherical
morphology with a relatively uniform and porous structure and
a diameter of 7.0 0.003 mm (Fig. 2a). The morphology and size
distribution did not show obvious differences aer reaction
with g-aminopropyltriethoxysilane followed by 6-chlorohex-
anoic acid (Fig. 2b and c); the linkers had little effect on the
silica gel structure. Larger particles with a diameter of 7.035 
0.005 mm were observed when 6-chlorohexanoic-silica was
treated with b2-AR, AT1 and AT2 (Fig. 2d–f). The changes were
conrmed at higher magnications (ESI Fig. 1†). GPCRs such as
b2-AR, AT1 and AT2 have diameters of approximately
10.0 nm.38,39 Taking the size of the Halo-tag into account, the
diameters of the three Halo-tagged receptors were calculated to
be approximately 20.0 nm, which is 50% of the change in size
of the receptor-conjugated microspheres compared to the
control supports. This result conrmed that the surfaces of the
microspheres were evenly coated with a monolayer of the
receptors.
As shown in the insets of Fig. 2, distinct features of the
receptor-conjugated microspheres were observed at higher
magnication. All of the three receptor-conjugated micro-
spheres exhibited a rough surface compared to the bare
microspheres. To examine if the surface appearance was caused
by the Halo-tagged receptor coatings, the receptor-conjugated
microspheres and bare microspheres were calcinated at
600 C for 6.0 h. Aer destroying the receptors at high
temperature, the receptor-conjugated microspheres were
similar in size and morphology to the bare microspheres, as
expected (ESI Fig. 2†). This observation suggested that the
morphological changes observed in the receptor-conjugated
microspheres were attributable to the immobilized receptors.
Subsequent experiments using TEM clearly demonstrated
that receptors were bound to the entire surface of the micro-
spheres. Distinct irregular protuberances were visualized on the
receptor-conjugated microspheres (ESI Fig. 3†). Elemental
analysis of the protuberances revealed high carbon content,
conrming that receptor immobilization had occurred. The
receptor-conjugated microspheres appeared as a milky and
gleaming layer over the spherical surface, indicating the pres-
ence of a homogeneous layer of receptors; no such layer was
observed on the control supports. Immuno-TEM images of the
b2-AR-conjugated microspheres displayed a larger size and
a rougher surface than the 6-chlorohexanoic acid coated gel,
thus conrming this layer (ESI Fig. 4†).
In Fig. 3, 40 nm cross-sections of linker-coated and receptor-
conjugated microspheres imaged with TEM clearly show
microspheres with dense and sharp differences from oneThis journal is © The Royal Society of Chemistry 2018
Fig. 2 SEM micrographs of silica gel coatings: (a) bare silica gel; (b) aminopropyl silica gel; (c) 6-chlorohexanoic acid-coated gel; (d) b2-AR-
coated gel; (e) AT1-coated gel; (f) AT2-coated gel.
























































































View Article Onlineanother. The pores within the microsphere are visible as light
areas, whereas the matrices of the silica gel can be seen as dark
regions. The continuous grey layer identied as an epoxy resinFig. 3 TEM images of a 40 nm cross-section of linker-coated silica ge
magnifications of 2500 (b), 63 000 (c) and 145 000 (d).
This journal is © The Royal Society of Chemistry 2018was clearly discriminated from the silica gel. The control
supports and immobilized receptors exhibited irregularly sha-
ped pores with a large distribution, which is in agreement withl at magnification of 2500 (a) and receptor-conjugated silica gel at
Chem. Sci., 2018, 9, 446–456 | 449
























































































View Article Onlineprevious reports of wide-pore silica gels.40 At higher magni-
cations (Fig. 3), the dark matrices were surrounded by a thin
grey lm, where we speculated the Halo-tagged receptors are
located. When the cross-section was placed over a Quantifoil/
Cu hole to minimize background interference, larger areas of
grey lm were observed in the receptor-conjugated micro-
spheres, and their pores appeared more lled compared to the
linker-coated supports. This result was further conrmed by
high angle annular dark eld imaging (HAADF) and dual
energy dispersive spectroscopy (EDS). At the end of each line of
STEM-EDS acquisition, quick HAADF images were obtained to
check and eliminate any residual sample-dri by cross-
correlation. The image was acquired at 256  256 pixels with
multiple frame acquisition, with a total acquisition time of
approximately 10 min. The STEM-HAADF image and STEM-
EDS chemical maps for the b2-AR conjugated microsphere
cross-section were shown in Fig. 4. Compared to the images of
the control spheres (ESI Fig. 5†), Fig. 4 demonstrated the non-
homogeneous and spatial elemental distribution of carbon,
oxygen and nitrogen across the spheres. It is evident that the
three receptor-conjugated spheres are richer in these elements
than the control spheres. This nding was also conrmed with
EDS (ESI Fig. 6†); the weight percentages of carbon, oxygen
and nitrogen in the receptor-conjugated spheres were
substantially higher than in the control sphere. These results
indicate that the linker-modied silica gel was successfully
coated with Halo-tagged receptors. Collectively, from the XPS,
SEM and TEM data, we concluded that all three Halo-tagged
receptors are immobilized on the silica gel as a homogenous
monolayer.Fig. 4 STEM-HAADF image (left) and STEM-EDS chemical maps (right)
450 | Chem. Sci., 2018, 9, 446–456Function of the immobilized receptors
The immobilized receptors bound preferentially to specic
phospholipids. Phospholipids are key players inmodulating the
structure and function of membrane proteins. Their effects on
GPCRs have been studied by following protein function aer
reconstitution in given environments. To investigate whether
the immobilized receptors are surrounded by certain bound
lipids aer immobilization, we extracted the receptor-
conjugated silica gel by the method of Bligh and Dyer.41 We
then identied and quantitatively measured the phospholipids
in the extraction. This allowed us to compare the relative
amounts of certain phospholipids bound to the immobilized
receptor with those found in E. coli membranes.
The three immobilized receptors appeared to favor the
binding of specic PG species such as PG C18:1/C18:1 (ESI Fig. 7
and Table 3†). The total specic PG species found on each
immobilized receptor was increased up to 8-fold compared with
their abundance in the bacterial cell membrane. For the case of
PE, we observed lower relative enrichment. These results were
anticipated since the use of detergent for receptor solubilization
was avoided in this work. Taking inspiration from previous
reports where the modulation of lipids on membrane protein
structure and activity are attributed to the binding of specic
lipids to the protein surface even in the absence of a bilayer,42
we reasoned that the functions of the three immobilized
receptors were partly owing to their surrounding environments
of bound lipids.
The immobilized receptors exhibited radio-ligand binding
ability. Saturation experiments with [125I]-CYP as a radio-ligand
showed specic saturated binding isotherms. The high-affinity
binding data of CYP to both the cells and the immobilized b2-ARof a b2-AR-conjugated silica gel cross-section.
This journal is © The Royal Society of Chemistry 2018
























































































View Article Onlinewere well tted to a one-site hyperbolic binding curve using
nonlinear regression analysis (ESI Fig. 8a†). The total number of
receptors (Bmax) on the desired cells and the receptor-conju-
gated microsphere were 330 6 pmol per mg protein and 423
7 nmol per g gel. The dissociation constants were measured as
19.34  1.04 pM (n ¼ 10) and 19.90  0.91 pM (n ¼ 10). The
specic b2-AR antagonist (ICI 118,551) displaced CYP in
a monophasic displacement pattern, resulting in an IC50 value
of 14.5  1.1 nmol l1 for the immobilized receptor (ESI
Fig. 8b†). [125I]-[Sar1, Ile8]AngII displayed a higher affinity for
AT1 than AT2 not only in E. coli cells but also on the surface of
the silica gel. The dissociation constants of the interactions
between [125I]-[Sar1, Ile8]AngII and the two immobilized recep-
tors were 0.28  0.02 and 0.087  0.006 nM (ESI Fig. 9a†),
respectively. Competitive binding analysis exhibited IC50 values
of 4.80 0.04 nmol l1 for losartan to AT1 and 0.84 0.05 nmol
l1 for PD123319 to immobilized AT2 (ESI Fig. 9b†). These data
demonstrate that there is a high population of b2-AR, AT1 or AT2
on the three kinds of silica gel. The immobilized receptors were
specic in recognizing their ligands, and thereby had ligand
induced pharmacological functions.
The immobilized receptors demonstrated ligand-induced
conformational changes. We applied LSM to gain further
insight into the activity, orientation and conformation of the
immobilized receptors. All of the receptors in this work were
created using a synthetic gene to encode the particular receptor
with the desired C-terminal enzyme tag. This structural prop-
erty requires the receptor domain to specically recognize its
ligand and the tag to efficiently bind to an optimal linker. To
ensure the functional integrity of the three Halo-tagged recep-
tors, we measured the activities of their enzyme domains and
ligand-binding regions.
First, we examined the activity of dehalogenase incorporated
in the receptors, which were expressed in E. coli. A uorescent
carboxytetramethylrhodamine ligand (Halo-tag® TMR ligand)
was utilized to recognize and label the dehalogenase domains
of the fusion receptors for imaging analysis using LSM.
Compared with a control vector not expressing the receptors,
clear uorescence signals were observed in the E. coli expressing
b2-AR, AT1 and AT2 (ESI Fig. 10†), indicating that dehalogenase
was successfully incorporated into the structures of the three
receptors. This result also conrmed that the dehalogenase in
the receptors could form a covalent ester bond with haloalkane
functionalities via the nucleophilic displacement of halides.
The next set of experiments was designed to reveal whether the
dehalogenase fused to the receptors retained catalytic activity in
a solid–liquid interface. To this end, we covalently linked sal-
butamol (a specic ligand for b2-AR) and angiotensin II (a
specic ligand for AT1 and AT2) onto silica gel (ESI Fig. 11†) to
prepare affinity adsorbents capable of capturing the target
receptors and orienting the dehalogenase domain outwards.
We stated that the attachment of salbutamol may affect its
binding to b2-AR. Such an inuence was ignorable when
investigating the catalytic activity of the three Halo-tagged
receptors using the current strategy. As a non-catechol strong
partial agonist of b2-AR, salbutamol has a protonated secondary
amine nitrogen with a tertiary butyl group attached to it, a b-OHThis journal is © The Royal Society of Chemistry 2018group, one OH group and another –CH2OH group on the
aromatic ring. These functional groups produce several kinds of
binding site to b2-AR. Asp
113 makes a strong salt-bridge contact
with the protonated amine (distance, 2.9 Å). Due to the long
–CH2OH group of salbutamol, a smaller rotation of TM5 places
the serines in close proximity to the hydroxyl groups of the drug.
Asp113 simultaneously generates a hydrogen bond with the b-
OH. The presence of a bulky alkyl –(CH3)3 group at one end
enables salbutamol to interact with TM7. Leu311 shows favor-
able van der Waals interaction with the alkyl group of salbuta-
mol. In this work, salbutamol was attached on the surface of
silica gel through the use of phenol hydroxyl. There is a linker of
six atoms between the gel surface and salbutamol, which allows
salbutamol to be exible and rotatable during the binding
process. Therefore, we believe that salbutamol still has
a binding activity to b2-AR aer attachment.
These adsorbents were used to immobilize the three recep-
tors to assess the catalytic activity using the Halo-tag® TMR
ligand as a uorescence marker. No uorescence was observed
for the control adsorbents, including bare or salbutamol/
angiotensin II-coated silica gel, whereas intense orescence
was observed in both salbutamol and angiotensin II-coated gel
treated with the corresponding receptors (ESI Fig. 12†). This
result indicated that the dehalogenase domains of the three
fusion receptors retain catalytic activity even aer immobiliza-
tion on solid matrices.
The number of cysteine residues in the gene sequences of b2-
AR (13), AT1 (10) and AT2 (14) is much greater than that of the
dehalogenase (2) incorporated into the receptors, implying that
thiols are more prevalent in the receptor domains of the three
Halo-tagged proteins. Cyanine5 maleimide was selected as
a uorescence marker to explore the ligand-binding activity of
the Halo-tagged receptors. The control supports made of bare
silica gel, aminopropyl silica gel and 6-chlorohexanoic acid-
coated gel showed little uorescence (Fig. 5a–c), but intense
uorescence was observed when the 6-chlorohexanoic acid-
coated gel was treated with the three Halo-tagged receptors
(Fig. 5d–f). The uorescence distribution in each microsphere
was uniform and contrasted sharply against the surrounding
liquid environment. Using 6-chlorohexanoic acid-coated gel as
the support, we visualized less uorescence than the three Halo-
tagged receptors when dehalogenase itself was immobilized
(ESI Fig. 13†). This result suggested the uniform distribution of
Halo-tagged receptors on the surface of the silica gel and
conrmed covalent attachment without physical immobiliza-
tion of the receptors.Conformation regulation by specic ligands
GPCRs are involved in nearly every in vivo physiological process
via direct or indirect pathways. These biological responses are
typically mediated through ligand-induced conformational
changes, which activate heterotrimeric G proteins and lead to
the generation of second messengers. Pioneering studies have
proposed the classic receptor theory of active and inactive
receptor conformations. The active conformation of the
receptor is responsible for interacting with and activating all ofChem. Sci., 2018, 9, 446–456 | 451
Fig. 5 Cyanine5maleimide-labelled silica gel coatings: (a) bare silica gel; (b) aminopropyl silica gel; (c) 6-chlorohexanoic acid-coated gel; (d) b2-
AR-coated gel; (e) AT1-coated gel; (f) AT2-coated gel. The micrographs were obtained at a magnification of 40 using a Nikon C2 Plus confocal
microscope with appropriate filter sets. Scale bar: 50 mm.
























































































View Article Onlinethe messengers. Agonists with different efficacies modulate the
equilibrium between the active and inactive receptor confor-
mations. Full agonists stabilize the active state completely,
whereas partial agonists have no effect on the relative propor-
tion of each state due to an equilibrium shi caused by stabi-
lizing an inactive state or by occupying the orthosteric ligand-
binding pocket. Recent evidence has challenged this classical
view, suggesting that the ligand-induced receptor response is
nonlinear. As a model GPCR, b2-AR has been found to signal
through both G proteins and b-arrestins, which provides
evidence for the existence of multiple independent signalling
pathways downstream of the receptors. The possible existence
of diverse receptor conformations has been investigated using
MS-based quantitative analysis.43 Despite these insights into
agonist-induced receptor conformational changes, such studies
have not aided the study of immobilized GPCR conformations.
To develop an approach allowing the analysis of the confor-
mational changes in immobilized proteins, we utilized cyanine5
maleimide as a uorescent reagent to selectively label the thiol
groups of the Halo-tagged b2-AR, AT1 and AT2 conjugated to the
surface of the silica microspheres. The ligand-specic confor-
mations of each labelled receptor were identied using three
structurally and functionally distinct ligands (ESI Fig. 14†). In
opposition to the two-state conformation theory, the uores-
cence intensities of Halo-tagged b2-AR pre-treated with a full
agonist (isoproterenol), a partial agonist (salbutamol) and an
antagonist (carazolol) were clearly different from each other
(Fig. 6). Similar results were obtained for the Halo-tagged AT1
and AT2 when the two receptors were treated with correspond-
ing specic ligands. These results indicate that the immobilized
receptors have at least three ligand-induced conformations and
conrm that receptor–ligand binding activity is nonlinear.452 | Chem. Sci., 2018, 9, 446–456Here, we described a powerful approach capable of exam-
ining site-specic conformational changes in immobilized
proteins. Using this methodology, we conrmed that immobi-
lized GPCRs, including b2-AR, AT1 and AT2, occupy multiple
conformations upon ligand stimulation. This result can
profoundly inform the development of immobilized protein-
based methodologies such as enzyme reactors, protein micro-
arrays, biosensors and affinity chromatography. The basis for
this effect might be the crucial role of conformational changes
in bridging ligand binding affinity and therapeutic effects,
thereby extending the potential application of these techniques.Chromatographic analysis
Based on the above mentioned characterization, we speculated
that our immobilization strategy enabled higher density and
improved activity of the receptors on solid support surfaces.
Using b2-AR as a probe, we synthesized the immobilized
receptor (Fig. 7) and tested this hypothesis by exploring the
interaction between three drugs and the receptor with a set of
chromatographic experiments. We observed diverse retention
times for isoproterenol, salbutamol and carazolol on a column
containing immobilized b2-AR (Fig. 8). The b2-AR antagonist
carazolol showed a much longer retention time than isopro-
terenol (agonist) and salbutamol (partial agonist), conrming
the ligand recognition specicity of immobilized b2-AR. Despite
the asymmetry and peak tailing in the chromatographic
proles, remarkable improvements in peak width were attained
compared to previous reports attaching b2-AR onto silica gel
using a diazo reaction or the N,N0-carbonyldiimidazole method.
These improvements stem from the relatively homogeneous
monolayer of b2-AR formed using this method.This journal is © The Royal Society of Chemistry 2018
Fig. 6 Ligand-induced conformational changes of immobilized b2-AR with: (a) no ligand; (b) isoproterenol; (c) salbutamol; (d) carazolol.
Cyanine5 maleimide was used as a probe to label the receptor. The micrographs were obtained at a magnification of 40 using a Nikon C2 Plus
confocal microscope with appropriate filter sets. Scale bar: 50 mm.
























































































View Article OnlineUsing nonlinear chromatography, we calculated the binding
parameters of the three drugs to the immobilized b2-AR. ESI
Table 4† summarizes the capacity factors, association constants
and rate constants determined in this work and collected from
the literature.44,45 Compared to previous chromatographic
investigations, the current immobilization methodology
provided increased association constants of b2-AR for the three
drugs. These results are expected, as our strategy has the unique
advantage of minimizing the loss of protein bioactivity becauseFig. 7 Diagram of the selective covalent capture of Halo-tagged recept
This journal is © The Royal Society of Chemistry 2018isolation and purication of the protein is not necessary. These
results, in particular the improved retention of protein bioac-
tivity, have conrmed the merits of this proposed methodology.
Experimental
Plasmid cloning and construction
Plasmids encoding the b2-AR, AT1 and AT2 genes with the Halo
gene at their C-terminus were constructed using BP and LRors onto a chloroalkane linker-coated macroporous silica gel.
Chem. Sci., 2018, 9, 446–456 | 453
Fig. 8 Representative chromatograms of ligands on an immobilized b2-AR column. Peaks are identified as: (a–d). (a) Void time determined from
isoproterenol after the column was treated with 7 M guanidine hydrochloride; (b), salbutamol; (c), isoproterenol; (d), carazolol.
























































































View Article Onlinereactions in E. coli. DNA fragments for the b2-AR (Accession:
NM_000024.5), AT1 (Accession: BC068494.1) and AT2 (Acces-
sion: BC095504.1) encoding attB1 and attB2 recombination
sites were supplied by GeneCopoeia (Guangdong, China). To
create entry clones, we mixed these DNA fragments with shuttle
vectors containing attP1 and attP2 sites, followed by the addi-
tion of 5 BP Clonase™ Reaction buffer, BP Clonase™ enzyme
mix and distilled water. Aer a 2.0 h reaction at 25 C, we
utilized a1 proteinase K to block the BP Clonase™ enzyme. Two
microliters of the three products were transformed into E. coli
TOP10 cells for the selection of kanamycin-resistant entry
clones. The three entry clones encoding b2-AR, AT1 and AT2 DNA
fragments were transformed into the destination vector
pReceiver-ccdB-Halo containing attR1 and attR2 sites using the
LR recombination reaction to generate the expression clones
pReceiver-b2-AR-Halo, pReceiver-AT1-Halo and pReceiver-AT2-
Halo.
Protein expression
The expression clones were transformed into E. coli BL21(DE3)
to select positive clones with ampicillin resistance. The selected
clones were cultured in LB media at 37 C overnight and then
seeded in auto-induction growth media for an additional 12.0 h
incubation. The pellets were collected by centrifugation, sus-
pended in lysis buffer and incubated for 30 min at 37 C. The
bacterial suspension was kept in an ice-bath and sonicated. The
disrupted bacterial suspension was centrifuged, and the
supernatant was used for the immobilization of the Halo-tagged
b2-AR, AT1 and AT2 without further purication.
Immobilization of fused receptors
Aminopropyl silica gel was activated with the desired linkers
using an acylation reaction under the following conditions:
solvent ¼ DMF, condensing agent ¼ 1-bis(dimethylamino)
methylene-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexa-
uorophosphate, accelerant ¼ N,N-diisopropylethylamine,
temperature¼ 25 C and duration¼ 2.0 h. The linker-coated gel
was immersed in crude lysates containing the Halo-tagged b2-
AR, AT1 and AT2 with stirring for 1.0 h to prepare the receptor-
conjugated microspheres. The physically adsorbed proteins
were removed with phosphate buffer (20.0 mM, pH 7.4).454 | Chem. Sci., 2018, 9, 446–456X-ray photoelectron spectroscopy
X-ray photoelectron spectroscopy was performed in a VG
ESCALAB220i-XL analyser (Thermo Scientic, Surrey, UK) at an
ultrahigh vacuum surface analytical facility with a base vacuum
of 1.0  108 Pa. Monochromatic Al Ka (1486.6 eV, 14.5 kV, 30
mA) was utilized as the incident radiation with a pass energy of
200 eV. The binding energies were calibrated with respect to the
C 1s peak at 284.8 eV. A combination of a Shirley-type back-
ground and a linear-type background was used for curve tting.
All of the ttings were performed using Voigt-shaped peaks with
an equal FWHM for each data set.
Cryo-eld emission scanning electron microscopy
The surfacemorphology for all of the samples was characterized
using a Su 8010 (Hitachi, Japan) cryo-eld emission scanning
electron microscope equipped with a cryo-eld emission gun,
lower and upper secondary electron detectors and a Genesis
soware system. The samples were transferred under vacuum to
the cryo-SEM sample preparation chamber, where the sample
temperature was maintained at 150 C by seating the sample
holder on a cold stage. The samples were subsequently frac-
tured using a cold knife to reveal a clean surface. The images
were acquired at an accelerating voltage of 2 kV and a working
distance of 4–5 mm.
High resolution transmission electron microscopy
The inner microstructure of all of the samples was assessed
with a FEI Tecnai G2 F20 S-Twin (FEI, Houston, TX, USA)
transmission electron microscope equipped with a eld emis-
sion gun, a scanning unit with a high angular annular dark eld
detector (HAADF) and an energy-dispersive X-ray spectroscope
(EDAX, Tilburg, The Netherlands). The microscope was
controlled by running programs, including a Tecnai user
interface, a digital micrograph and Tecnai imaging and anal-
ysis. Electron micrographs were recorded either on photo-
graphic lm or with a CCD camera under low-dose conditions.
HPLC/MS/MS conditions for phospholipid identication
HPLC/MS/MS analyses of the phospholipids were performed
using an Agilent 1100 LC-MSD system (Agilent Technologies,This journal is © The Royal Society of Chemistry 2018
























































































View Article OnlineWaldbronn, Germany) consisting of a quaternary pump
(G1311A), a column thermostat (G1316A), a diode-array detector
(1315B), and an ion trap MS with an electrospray ionization
(ESI) tandem MS interface. Data acquisitions and processing
were carried out using a MSD Trap Control and Data Analysis
4.2 data system. LC separations were obtained on an Inertsil
ODS-3 C-18 column (4.6  150 mm, 5 mm) at room temperature
using ammonium acetate (5 mM) (Solvent A) and acetonitrile
(Solvent B) in gradient elution at a ow rate of 0.5 mlmin1. The
gradient elution was performed as follows: aer 10 min of iso-
cratic elution (Solvent A 50%), Solvent B was increased from
50% to 95% in 25min along a linear gradient curve and the nal
elution was held for another 30 min. The injections were carried
out with a Rheodyne model 7725i (Interchim, Montluçon,
France) valve equipped with a 20 ml loop. The optimized ESI
parameters for negative ion detection were capillary voltage set
at +3.5 kV with a scan range from 100 to 1500 m/z. Nitrogen was
used as the drying (10 l min1, 350 C) and nebulizing (30 psi)
gas.
Radio-ligand binding assay
Saturation binding assays were performed with [125I]-
cyanopindolol for b2-AR and [
125I]-[Sar1, Ile8]AngII for AT1 and
AT2. Nonspecic binding was determined in the presence of 1
mM DL-propranolol for b2-AR and 1 mM unlabeled [Sar
1, Ile8]
AngII for AT1 and AT2. Competitive binding assays were carried
out using various concentrations of ICI 118,551 (b2-AR selective
antagonist), losartan (AT1 selective antagonist) and PD123319
(AT2 selective antagonist) as competitive agents. The specic
binding was determined by subtracting the nonspecic binding
from the total binding.
Confocal microscopy analysis
Confocal microscopy analysis was performed with a Nikon C2
Plus confocal microscope (C2+ Nikon, Tokyo, Japan). This
microscope provides 4 laser lines (405, 488, 561 and 640 nm)
and is able to take images with up to 2048  2048 pixels reso-
lution. The samples were placed over glass slides, covered with
glass cover slips and exposed to the microscope. Images were
captured and processed using the NIS ELEMENTS soware
provided with the instrument.
Conclusion
This study presents a simple bioorthogonal approach for the
oriented covalent immobilization of b2-AR, AT1 and AT2 onto
microspheres as well as a comprehensive protocol to charac-
terize themorphology and activity of immobilized receptors and
validate their application in receptor chromatography for
ligand–receptor interaction analysis. The immobilization
strategy is fast, robust, chemoselective and has a high yield and
the unique advantage of minimizing the loss of protein func-
tion. This method has the potential to become a universally
applicable alternative for protein immobilization on solid
supports with high efficiency, especially for proteins with low
solubility. The methodology for characterizing receptor-This journal is © The Royal Society of Chemistry 2018conjugated microspheres can assess protein morphology,
ligand binding activity and ligand-induced conformational
changes. These characterization methods are particularly
important in the development of sensitive, immobilized
protein-based techniques including bioreactors, microarrays
and biosensors to carefully probe biological processes. Receptor
chromatography is useful for the study of ligand–receptor
interactions. It is a powerful platform for rapid ligand–receptor
binding analysis and drug candidate screening.Conflicts of interest
The authors declare no competing nancial interests.Acknowledgements
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